Catalyst Pharmaceuticals
CPRX
#4019
Rank
โ‚ฌ2.51 B
Marketcap
20,50ย โ‚ฌ
Share price
-1.14%
Change (1 day)
-6.88%
Change (1 year)

Revenue for Catalyst Pharmaceuticals (CPRX)

Revenue in 2025 (TTM): โ‚ฌ0.51 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.48 Billion. In 2024 the company made a revenue of โ‚ฌ0.47 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ0.36 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Catalyst Pharmaceuticals from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.51 B9.57%
2024 โ‚ฌ0.47 B31.18%
2023 โ‚ฌ0.36 B80.39%
2022 โ‚ฌ0.19 B60.58%
2021 โ‚ฌ0.12 B28.45%
2020 โ‚ฌ96.8 M6%
2019 โ‚ฌ91.32 M20795.34%
2018 โ‚ฌ0.43 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A-100%
2010 โ‚ฌ0.36 M
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ77.73 B 15,837.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ52.96 B 10,758.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ36.98 B 7,482.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ2.03 B 317.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ97.57 M-80.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ2.61 B 435.11%๐Ÿ‡บ๐Ÿ‡ธ USA